Phthalate metabolites in urine of CF patients are associated with use of enteric-coated pancreatic enzymes

Environmental Toxicology and Pharmacology - Tập 27 - Trang 424-427 - 2009
Bernd O. Keller1, A. George F. Davidson2,3, Sheila M. Innis2
1Department of Pathology and Laboratory Medicine, University of British Columbia, Child & Family Research Institute, Vancouver, Canada
2Nutrition Research Program, Department of Paediatrics, University of British Columbia, Child & Family Research Institute, 950 West 28th Avenue, Vancouver, BC, Canada V5Z 4H4
3Cystic Fibrosis Clinic, British Columbia Children's Hospital, Vancouver, Canada

Tài liệu tham khảo

Centers for Disease Control Prevention, 2005 Dominguez-Munoz, 2007, Pancreatic enzyme therapy for pancreatic exocrine insufficiency, Curr. Gastroenterol. Rep., 9, 116, 10.1007/s11894-007-0005-4 Ferrone, 2007, Pancreatic enzyme pharmacotherapy, Pharmacotherapy, 27, 910, 10.1592/phco.27.6.910 Frederikson, 2007, Metabolites of phthalates in humans, Mol. Nutr. Food Res., 51, 899, 10.1002/mnfr.200600243 Hauser, 2004, Medications as a source of human exposure to phthalates, Environ. Health Perspect., 112, 751, 10.1289/ehp.6804 Hultcrantz, 1986, Morphological findings in the liver of children with cystic fibrosis: a light and electron microscopy study, Hepatology, 6, 881, 10.1002/hep.1840060513 Innis, 2008, Cystic fibrosis and nutrition: linking phospholipids and essential fatty acids with thiol metabolism, Annu. Rev. Nutr., 28, 55, 10.1146/annurev.nutr.27.061406.093625 Innis, 2007, Choline related supplements improve abnormal plasma methionine-homocysteine metabolites and glutathione status in children with cystic fibrosis, Am. J. Clin. Nutr., 85, 702, 10.1093/ajcn/85.3.702 Innis, 2006, Evidence of choline depletion with reduced betaine and dimethylglycine with increased homocysteine in children with cystic fibrosis, J. Nutr., 136, 2226, 10.1093/jn/136.8.2226 Innis, 2003, Increased plasma homocysteine and S-adenosylhomocysteine and decreased methionine is associated with altered phosphatidylcholine and phosphatidylethanolamine in cystic fibrosis, J. Pediatr., 143, 351, 10.1067/S0022-3476(03)00326-3 Mapuskar, 2007, Dose-dependent sub-chronic toxicity of diethylphthalate in female Swiss mice, Pest. Biochem. Physiol., 87, 156, 10.1016/j.pestbp.2006.07.005 Pereira, 2006, Chronic toxicity of diethyl phthalate in male Wistar rats – a dose–response study, Regul. Toxicol. Pharmacol., 45, 169, 10.1016/j.yrtph.2006.04.006 Pereira, 2007, Chronic toxicity of diethyl phthalate. A 3 generation lactational and gestational exposure study on male Wistar rats, Environ. Toxicol. Pharmacol., 23, 319, 10.1016/j.etap.2006.12.005 Rosenfeld, 2000, Early pulmonary infection, inflammation and clinical outcomes in infants with cystic fibrosis, Pediatr. Pulmomol., 32, 356, 10.1002/ppul.1144 Roum, 1993, Systemic deficiency of glutathione in cystic fibrosis, J. Appl. Physiol., 75, 2419, 10.1152/jappl.1993.75.6.2419 Sathyanarayana, 2008, Phthalates and children's health, Curr. Probl. Pediatr. Adolesc. Health Care, 38, 34, 10.1016/j.cppeds.2007.11.001 Shea, 2003, Pediatric exposure and potential toxicity of phthalate plasticizers, Pediatrics, 111, 1467, 10.1542/peds.111.6.1467 Silva, 2007, Metabolite profiles of di-n-butyl phthalate in humans and rats, Environ. Sci. Technol., 41, 7576, 10.1021/es071142x Wolff, 2007, Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls, Environ. Health Perspect., 115, 116, 10.1289/ehp.9488